124 related articles for article (PubMed ID: 30322558)
1. Magnetic-bioluminescent-nanoliposomes for ultrasensitive and portable detection of protein biomarkers in blood.
Liu P; Fang X; Cao H; Gu M; Kong J; Deng A
Anal Chim Acta; 2018 Dec; 1039():98-107. PubMed ID: 30322558
[TBL] [Abstract][Full Text] [Related]
2. One-step detection for two serological biomarker species to improve the diagnostic accuracy of hepatocellular carcinoma.
Gao T; Zhi J; Mu C; Gu S; Xiao J; Yang J; Wang Z; Xiang Y
Talanta; 2018 Feb; 178():89-93. PubMed ID: 29136911
[TBL] [Abstract][Full Text] [Related]
3. An electrochemical biosensor for the assay of alpha-fetoprotein-L3 with practical applications.
Li J; Gao T; Gu S; Zhi J; Yang J; Li G
Biosens Bioelectron; 2017 Jan; 87():352-357. PubMed ID: 27587360
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
5. Color-Encoded Assays for the Simultaneous Quantification of Dual Cancer Biomarkers.
Ma J; Zhan L; Li RS; Gao PF; Huang CZ
Anal Chem; 2017 Aug; 89(16):8484-8489. PubMed ID: 28732160
[TBL] [Abstract][Full Text] [Related]
6. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
Wu Y; Ma J; Wang Y; Zhang Y; Hou Y; Zhang C; Sun H; Sun J; Wang Z; Li N
Clin Chim Acta; 2018 Jul; 482():209-214. PubMed ID: 29630871
[TBL] [Abstract][Full Text] [Related]
7. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
[TBL] [Abstract][Full Text] [Related]
8. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
9. Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray.
Wu M; Liu H; Liu Z; Liu C; Zhang A; Li N
J Int Med Res; 2018 Oct; 46(10):4297-4305. PubMed ID: 30111217
[TBL] [Abstract][Full Text] [Related]
10. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
12. Label-free detection of biomarker alpha fetoprotein in serum by ssDNA aptamer functionalized magnetic nanoparticles.
Su Y; Xue T; Wu L; Hu Y; Wang J; Xu Q; Chen Y; Lin Z
Nanotechnology; 2020 Feb; 31(9):095104. PubMed ID: 31726443
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar.
Taketa K; Okada S; Win N; Hlaing NK; Wind KM
Acta Med Okayama; 2002 Dec; 56(6):317-20. PubMed ID: 12685861
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology - a prospective study.
Chaminda SR; Suchintha T; Anuk NM; Supun DA; Bhagya GM; Habarakada LCA; Janaka SH
BMC Gastroenterol; 2017 Dec; 17(1):142. PubMed ID: 29207969
[TBL] [Abstract][Full Text] [Related]
15. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
Abbasi A; Bhutto AR; Butt N; Munir SM
J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
[TBL] [Abstract][Full Text] [Related]
16. A study of diagnostic value of golgi protein GP73 and its genetic assay in primary hepatic carcinoma.
Shi Y; Chen J; Li L; Sun Z; Zen L; Xu S; Zhang Y; Zhang L
Technol Cancer Res Treat; 2011 Jun; 10(3):287-94. PubMed ID: 21517136
[TBL] [Abstract][Full Text] [Related]
17. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
18. Development of on-chip fully automated immunoassay system "μTASWako i30" to measure the changes in glycosylation profiles of alpha-fetoprotein in patients with hepatocellular carcinoma.
Kurosawa T; Watanabe M
Proteomics; 2016 Dec; 16(24):3056-3061. PubMed ID: 27272472
[TBL] [Abstract][Full Text] [Related]
19. A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.
Chen M; Zheng T; Han S; Zhang L; Bai Y; Fang X; Ding SZ; Yang Y
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):215-21. PubMed ID: 25312778
[TBL] [Abstract][Full Text] [Related]
20. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
